Tuesday, September 5, 2023 Daily Archives

GSK invests $268m at Belgium plant to support vaccine sales

by

With increasing demand for its shingles and RSV vaccines, GSK has invested $268 million to build a manufacturing center at its Wavre, Belgium site.  Shingrix, GlaxoSmithKline’s shingles vaccine, pulled in sales of £2.96 billion ($3 billion) in 2022, up 75% on the year prior. Meanwhile, the US Food and Drug Administration (FDA) approved the first respiratory syncytial virus (RSV) vaccine Arexvy earlier this year.  Such events have led the firm to invest €250 million ($268 million) to bolster its manufacturing operations…

September 5, 2023

eXmoor and Kincell team to meet CGT demand

by

eXmoor and Kincell aim to advance development and manufacturing services in Europe and the US to meet growing CGT demands for global clients. The two contract development manufacturing organizations (CDMOs) have partnered to bring together both companies’ CGT manufacturing capabilities across Europe and the US. The collaboration, of which financials have not been disclosed, looks to enable customers to access a global development and production footprint with different offerings from both parties. The partnership, of which financial details have not…

September 5, 2023